What Is Omisirge, and Why Does It Matter? Omisirge (omidubicel-onlv) is a type of cell therapy made from umbilical cord blood. It helps your body make new blood cells after a stem cell transplant.
The recommendation comes after the first at-home test, a self-swab, received federal approval last year. By Nina Agrawal An agency under the U.S. Department of Health and Human Services endorsed an ...
Hereditary spherocytosis (HS) is a genetic hemolytic disorder primarily characterized by hemolytic anemia, jaundice, splenomegaly, and frequent complications, including cholelithiasis, accompanied by ...
Disclosures: Has received honoraria, advisory boards, research funding from AbbVie, Alexion, BeiGene, BMS, Celgene, Fibrogen, Forma, Janssen, Novartis, Taiho ...
Abstract: The accurate classification of cancer cells in the peripheral blood is essential for the diagnosis of leukemia and has traditionally been carried out by analyzing laboratory images. In this ...
The following is a summary of “Mixed Autoimmune Hemolytic Anemia: A Systematic Review of Epidemiology, Clinical Characteristics, Therapies, and Outcomes,” published in the May 2025 issue of American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback